Skip to main content
PMC home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 1962 Aug;25(3):191–202. doi: 10.1136/jnnp.25.3.191

Sources of error in the biochemical diagnosis of muscular dystrophy1

W H S Thomson 1
PMCID: PMC495443  PMID: 14037852

Full text

PDF
192

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BAKER R. W., EVANS J. H. Serum aldolase and the diagnosis of myopathy. Brain. 1957 Dec;80(4):557–570. doi: 10.1093/brain/80.4.557. [DOI] [PubMed] [Google Scholar]
  2. BARRETT A. M., GRESHAM G. A. Acute streptococcal myositis. Lancet. 1958 Feb 15;1(7016):347–350. doi: 10.1016/s0140-6736(58)90971-1. [DOI] [PubMed] [Google Scholar]
  3. BLYTH H., PUGH R. J. Muscular dystrophy in childhood; the genetic aspect; a field study in the Leeds region of clinical types and their inheritance. Ann Hum Genet. 1959 Apr;23(2):127–163. doi: 10.1111/j.1469-1809.1958.tb01457.x. [DOI] [PubMed] [Google Scholar]
  4. BOMPIANI A. Attività glutamico-ossalacetico transaminasica del siero nella donna gravida, nella partoriente, nella puerpera. Ann Ostet Ginecol. 1956 Jun;78(6):705–717. [PubMed] [Google Scholar]
  5. BRETON A., GAUDIER B., TRAISNEL M., PONTE C. [Study of the level of serum transaminases and aldolase during myopathies]. Presse Med. 1959 Dec 26;67:2329–2331. [PubMed] [Google Scholar]
  6. BRUMLIK J., WACHS H., HUMMEL W., BOSHES B. Dermatomyositis; a discussion of the recent literature and report of two cases. Q Bull Northwest Univ Med Sch. 1959;33(1):22–28. [PMC free article] [PubMed] [Google Scholar]
  7. BRUNS F. Bestimmung und Eigenschaften der Serumaldolase. Biochem Z. 1954;325(2):156–162. [PubMed] [Google Scholar]
  8. CASULA D., CHERCHI P., SPINAZZOLA A. [Contribution to the blood enzyme picture during muscular work]. G Clin Med. 1961 May;42:499–513. [PubMed] [Google Scholar]
  9. CERRETELLI P., CANTONE A., MORANDINI M. L., MAMMANO R. [Effect of fatigue on the efflux of aldolase from isolated muscle]. Boll Soc Ital Biol Sper. 1959 Dec 31;35:1935–1937. [PubMed] [Google Scholar]
  10. CHUNG C. S., MORTON N. E., PETERS H. A. Serum enzymes and genetic carriers in muscular dystrophy. Am J Hum Genet. 1960 Mar;12:52–66. [PMC free article] [PubMed] [Google Scholar]
  11. DAVIS H. A. Pregnancy in myotonica dystrophia; a case report. J Obstet Gynaecol Br Emp. 1958 Jun;65(3):479–480. doi: 10.1111/j.1471-0528.1958.tb08542.x. [DOI] [PubMed] [Google Scholar]
  12. DREYFUS J. C., SCHAPIRA G., DEMOS J. Etude des différences artérioveineuses au cours des myopathies. 1. Oxygène, glucose et acide lactique. 2. Aldolase plasmatique. Clin Chim Acta. 1958 Nov;3(6):571–577. doi: 10.1016/0009-8981(58)90010-x. [DOI] [PubMed] [Google Scholar]
  13. DREYFUS J. C., SCHAPIRA G. L'activité transaminasique du sérum au cours des myopathies. C R Seances Soc Biol Fil. 1955 Nov;149(21-22):1934–1935. [PubMed] [Google Scholar]
  14. DUBACH U. C., STAMM H. O. Transaminasebestimmungen in der Geburtshilfe. Arch Gynakol. 1958;190(4):394–403. doi: 10.1007/BF00672659. [DOI] [PubMed] [Google Scholar]
  15. FRIEDMAN M. M., LAPAN B. Serum aldolase in the neonatal period: including a colorimetric determination of aldolase by standardization with dihydroxyacetone. J Lab Clin Med. 1958 May;51(5):745–752. [PubMed] [Google Scholar]
  16. GASPARDY G., KOVACS L., SIMON M., VIDA M. [On the problem of the pathogenesis of muscular atrophy in chronic polyarthritis]. Z Rheumaforsch. 1959 Dec;18:455–459. [PubMed] [Google Scholar]
  17. GENTILI C. [Significance of the increase of aldolase in blood in muscular dystrophy]. Clin Pediatr (Bologna) 1959 Sep;41:736–739. [PubMed] [Google Scholar]
  18. JACOB W., NEUHAUS J. Die Aktivität der Serumaldolase bei der progressiven Muskeldystrophie (ERB). Klin Wochenschr. 1954 Oct 1;32(37-38):923–924. doi: 10.1007/BF01467153. [DOI] [PubMed] [Google Scholar]
  19. KAESER H. E. [The behavior of serum glutamic acid-oxalacetic acid transaminase in myopathies and neurogenic muscle atrophies]. Dtsch Z Nervenheilkd. 1959;179:353–362. [PubMed] [Google Scholar]
  20. KARMEN A. A note on the spectrometric assay of glutamic-oxalacetic transaminase in human blood serum. J Clin Invest. 1955 Jan;34(1):131–133. [PubMed] [Google Scholar]
  21. KARMEN A., WROBLEWSKI F., LADUE J. S. Transaminase activity in human blood. J Clin Invest. 1955 Jan;34(1):126–131. doi: 10.1172/JCI103055. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. KRUH J., DREYFUS J. C., SCHAPIRA G., GEY G. O., Jr Abnormalities of muscle protein metabolism in mice with muscular dystrophy. J Clin Invest. 1960 Jul;39:1180–1184. doi: 10.1172/JCI104132. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. LAPAN B., FRIEDMAN M. M. A comparative study of fetal and maternal serum enzyme levels. J Lab Clin Med. 1959 Sep;54:417–426. [PubMed] [Google Scholar]
  24. LEYBURN P., THOMSON W. H., WALTON J. N. An investigation of the carrier state in the Duchenne type muscular dystrophy. Ann Hum Genet. 1961 May;25:41–49. doi: 10.1111/j.1469-1809.1961.tb01495.x. [DOI] [PubMed] [Google Scholar]
  25. MAAS O., PATERSON A. S. Myotonia congenita, dystrophia myotonica and paramyotonia; reaffirmation of their identity. Brain. 1950;73(3):318–336. doi: 10.1093/brain/73.3.318. [DOI] [PubMed] [Google Scholar]
  26. MARTONI L., MUSIANI S. Variazioni dell'attività aldolasica serica nell'età neonatale in condizioni fisiologiche, parafisiologiche e patologiche. Clin Pediatr (Bologna) 1958 May;40(5):397–409. [PubMed] [Google Scholar]
  27. MASON J. H., WROBLEWSKI F. Serum glutamic oxalacetic transaminase activity in experimental and disease states; a review. AMA Arch Intern Med. 1957 Feb;99(2):245–252. doi: 10.1001/archinte.1957.00260020081012. [DOI] [PubMed] [Google Scholar]
  28. MURPHY E. G., CHERNIAK M. M. Glutamic oxalacetic transaminase activity in the serum in muscular dystrophy and other neuromuscular disorders in childhood. Pediatrics. 1958 Dec;22(6):1110–1114. [PubMed] [Google Scholar]
  29. PEARSON C. M. Serum enzymes in muscular dystrophy and certain other muscular and neuromuscular diseases. I. Serum glutamic oxalacetic transaminase. N Engl J Med. 1957 Jun 6;256(23):1069–1075. doi: 10.1056/NEJM195706062562301. [DOI] [PubMed] [Google Scholar]
  30. PRYSTOWSKY H., HELLEGERS A. E., RANKE E., RANKE B., CHOW B. F. Further observations on the metabolism of vitamin B12 in human pregnancy. Am J Obstet Gynecol. 1959 Jan;77(1):1–5. doi: 10.1016/0002-9378(59)90260-1. [DOI] [PubMed] [Google Scholar]
  31. REITMAN S., FRANKEL S. A colorimetric method for the determination of serum glutamic oxalacetic and glutamic pyruvic transaminases. Am J Clin Pathol. 1957 Jul;28(1):56–63. doi: 10.1093/ajcp/28.1.56. [DOI] [PubMed] [Google Scholar]
  32. RICHTER K., KONITZER K. [Changes in aldolase activity in the blood serum during muscular work]. Klin Wochenschr. 1960 Oct 1;38:998–999. doi: 10.1007/BF01484314. [DOI] [PubMed] [Google Scholar]
  33. ROWELL N. R., SMITH A. J. Multiple serial enzyme studies in acute myocardial infarction. Br Med J. 1959 Sep 19;2(5150):459–463. doi: 10.1136/bmj.2.5150.459. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. ROWLAND L. P., ROSS G. Serum aldolase in muscular dystrophies, neuromuscular disorders, and wasting of skeletal muscle. AMA Arch Neurol Psychiatry. 1958 Aug;80(2):157–161. doi: 10.1001/archneurpsyc.1958.02340080027003. [DOI] [PubMed] [Google Scholar]
  35. SALVI G., AMBANELLI U., ROSATI G., CARRERAS M., MIRONI F. [Changes in serum glutamic oxalacetic transaminases and aldolases in muscle diseases, with special reference to Steinert's myotonic dystrophy]. Riv Patol Nerv Ment. 1959;80:1–12. [PubMed] [Google Scholar]
  36. SANTONI G. Sul diverso comportamento dell'attività glutammico-ossalacetico transaminasica sierica nel sangue materno, funicolo-placentare e del neonato. Ann Ostet Ginecol. 1956 Jun;78(6):718–724. [PubMed] [Google Scholar]
  37. SCHAPIRA F., DEMOS J., SCHAPIRA G., DREYFUS J. C. Facteurs de l'hyperaldolasémie au cours des myopathies. Rev Fr Etud Clin Biol. 1957 Sep;2(7):728–734. [PubMed] [Google Scholar]
  38. SCHAPIRA F., SCHAPIRA G., DREYFUS J. C. Hyperaldolasémie chez la souris myopathique. C R Hebd Seances Acad Sci. 1957 Aug 5;245(6):753–755. [PubMed] [Google Scholar]
  39. SCHAPIRA G., DREYFUS J. C., SCHAPIRA F. L'élévation du taux de l'aldolase sérique; test biochimique des myopathies. Sem Hop. 1953 Jun 10;29(38):1917–1920. [PubMed] [Google Scholar]
  40. SCHAPIRA G., KRUH J., DREYFUS J. C., SCHAPIRA F. The molecular turnover of muscle aldolase. J Biol Chem. 1960 Jun;235:1738–1741. [PubMed] [Google Scholar]
  41. SCHLANG H. A. The effect of physical exercise on serum transaminase. Am J Med Sci. 1961 Sep;242:338–341. doi: 10.1097/00000441-196109000-00009. [DOI] [PubMed] [Google Scholar]
  42. SIBLEY J. A., FLEISHER G. A. The clinical significance of serum aldolase. Proc Staff Meet Mayo Clin. 1954 Nov 10;29(23):591–603. [PubMed] [Google Scholar]
  43. SIBLEY J. A. Significance of serum aldolase levels. Ann N Y Acad Sci. 1958 Oct 13;75(1):339–348. doi: 10.1111/j.1749-6632.1958.tb36881.x. [DOI] [PubMed] [Google Scholar]
  44. SIEKERT R. G., FLEISHER G. A. Serum glutamic oxalacetic transaminase in certain neurologic and neuromuscular diseases. Proc Staff Meet Mayo Clin. 1956 Aug 8;31(16):459–464. [PubMed] [Google Scholar]
  45. SLATER E. C. Spectrophotometric determination of fructose-1:6-diphosphate, hexosemonophosphates, adenosinetriphosphate and adenosinediphosphate. Biochem J. 1953 Jan;53(1):157–167. doi: 10.1042/bj0530157. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. SOLTAN H. C. Muscular dystrophy in three pairs of twins. Acta Genet Med Gemellol (Roma) 1959 Oct;8:434–442. doi: 10.1017/s1120962300018618. [DOI] [PubMed] [Google Scholar]
  47. THOMPSON R. A., VIGNOS P. J., Jr Serum aldolase in muscle disease. AMA Arch Intern Med. 1959 Apr;103(4):551–564. doi: 10.1001/archinte.1959.00270040037004. [DOI] [PubMed] [Google Scholar]
  48. THOMSON W. H., LEYBURN P., WALTON J. N. Serum enzyme activity in muscular dystrophy. Br Med J. 1960 Oct 29;2(5208):1276–1281. doi: 10.1136/bmj.2.5208.1276. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. WALTON J. N., NATTRASS F. J. On the classification, natural history and treatment of the myopathies. Brain. 1954;77(2):169–231. doi: 10.1093/brain/77.2.169. [DOI] [PubMed] [Google Scholar]
  50. WHITE A. A., HESS W. C. Some alterations in serum enzymes in progressive muscular dystrophy. Proc Soc Exp Biol Med. 1957 Mar;94(3):541–544. doi: 10.3181/00379727-94-23006. [DOI] [PubMed] [Google Scholar]
  51. WHITE L. P. Some enigmas in the comparison of multiple serum enzyme levels. Ann N Y Acad Sci. 1958 Oct 13;75(1):349–356. doi: 10.1111/j.1749-6632.1958.tb36882.x. [DOI] [PubMed] [Google Scholar]
  52. WROBLEWSKI F., LADUE J. S. Serum glutamic pyruvic transaminase in cardiac with hepatic disease. Proc Soc Exp Biol Med. 1956 Apr;91(4):569–571. doi: 10.3181/00379727-91-22330. [DOI] [PubMed] [Google Scholar]
  53. ZIERLER K. L. Muscle membrane as a dynamic structure and its permeability to aldolase. Ann N Y Acad Sci. 1958 Oct 13;75(1):227–234. doi: 10.1111/j.1749-6632.1958.tb36869.x. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES